Author:
Mostafavi Ehsan,Ebrahimi Bahram,Doosti-Irani Amin,Mirzazadeh Ali
Publisher
Springer Science and Business Media LLC
Reference82 articles.
1. World Health Organization. HIV and hepatitis coinfections. World Health Organization [updated June 2017; cited 31 December, 2023]. Available from: http://www.who.int/hiv/topics/hepatitis/en/.
2. World Health Organization. Tuberculosis & HIV: World Health Organization; [cited 29 May 2024]. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/tuberculosis-hiv#:~:text=Tuberculosis%20(TB)%20remains%20the%20leading,million%20TB%20deaths%20that%20year.
3. Kouame GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, et al. Higher mortality despite early antiretroviral therapy in human immunodeficiency virus and hepatitis B virus (HBV)-coinfected patients with high HBV replication. Clin Infect Dis. 2018;66(1):112–20.
4. Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Muñoz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360(9349):1921–6.
5. Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797–808.